Except for treating sleep-related disorders, in Mbnl2–/– mice, mirtazapine, a kind of antidepressant, has been discovered to reverse cognitive impairments and depression, as well as reduce microglia and neuronal loss (Ramon-Duaso et al., 2020). The gene discussed is MBNL2; the disease is depressive symptom measurement.